SciBase Sees Increased Investment from Major Shareholders
SciBase, a leader in AI-based dermatology devices, has seen a significant increase in investment from its main shareholders. Announced in a press release, Ribbskottet AB and Life Science Investment Fund have each purchased approximately 7.5 million shares in a block trade. This transaction was conducted off the stock exchange from larger long-term owners.
Anders Bladh, CEO of Ribbskottet AB, expressed confidence in SciBase's growth and potential, citing the company's recent collaborations, including one with Castle Biosciences Inc. Jan Poulsen, CEO of Life Science Investment Fund, also highlighted the compelling investment opportunity presented by SciBase's current valuation.
SciBase specializes in early detection and prevention in dermatology, utilizing its Nevisense platform that combines AI and advanced EIS technology to enhance diagnostic accuracy. The company has been listed on the Nasdaq First North Growth Market since 2015.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Basecamp Research Raises $140 Million for AI Designed Therapeutics
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
RiskScout Raises Funding for AI Compliance Platform
Daily AI Brief: the AI news that matters, in your inbox.